As people with Down syndrome (DS) live longer, cognitive decline and Alzheimer's disease (AD) screening become crucial. Current neuropsychological tools for DS are often not validated in French or designed for AD diagnosis, highlighting a need for better assessment methods.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: